Hacettepe University Medical School is a medical school located at Hacettepe University Medical Center in Ankara, Turkey.

During the past decade, Hacettepe University Medical Faculty conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 32 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 24 clinical trials were completed. i.e. 68.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hacettepe University Medical Faculty" #1 sponsor was "Janssen Research & Development, LLC" with 12 trials, followed by "Pfizer" with 12 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Actelion" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hacettepe University Medical Faculty" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Ankara City Hospital Bilkent" with 2 trials as a collaborator, "Ankara Training and Research Hospital" with 2 trials as a collaborator, "Ankara University" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Hacettepe University Medical Faculty" are "COVID-19" (6 trials), "Crohn's Disease" (4 trials), "Arthritis, Psoriatic" (3 trials), "Blood Transfusion" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Hacettepe University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Hacettepe University Medical Faculty" are "Drug" (82 trials), "Other" (11 trials), "Biological" (5 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Carboplatin" (5 trials), "Pembrolizumab" (5 trials), "Cisplatin" (4 trials) and "Guselkumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hacettepe University Medical Faculty" are 95 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hacettepe University Medical Faculty". undefined are not yet recruiting, 22 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Hacettepe University Medical Faculty, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Hacettepe University Medical Faculty, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".